Clinical Trial Update: D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating D-Serine as an adjunct to cognitive retraining for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED